472 related articles for article (PubMed ID: 20575695)
21. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
[TBL] [Abstract][Full Text] [Related]
22. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
23. The use of metallic stents to bypass ureteral strictures secondary to metastatic prostate cancer: experience with 8 patients.
López-Martínez RA; Singireddy S; Lang EK
J Urol; 1997 Jul; 158(1):50-3. PubMed ID: 9186321
[TBL] [Abstract][Full Text] [Related]
24. Application of resonance metallic stents for ureteral obstruction.
Wang HJ; Lee TY; Luo HL; Chen CH; Shen YC; Chuang YC; Chiang PH
BJU Int; 2011 Aug; 108(3):428-32. PubMed ID: 21062397
[TBL] [Abstract][Full Text] [Related]
25. Success of ureteral stents for intrinsic ureteral obstruction.
Wenzler DL; Kim SP; Rosevear HM; Faerber GJ; Roberts WW; Wolf JS
J Endourol; 2008 Feb; 22(2):295-9. PubMed ID: 18294036
[TBL] [Abstract][Full Text] [Related]
26. [Retrospective analysis of the long-term indwelling ureteral stent].
Sakamoto H; Matsuda A; Kanno T; Yamada H
Hinyokika Kiyo; 2012 Jun; 58(6):269-72. PubMed ID: 22874504
[TBL] [Abstract][Full Text] [Related]
27. Metallic ureteral stents in malignant ureteral obstruction: clinical factors predicting stent failure.
Chow PM; Hsu JS; Huang CY; Wang SM; Lee YJ; Huang KH; Yu HJ; Pu YS; Liang PC
J Endourol; 2014 Jun; 28(6):729-34. PubMed ID: 24397490
[TBL] [Abstract][Full Text] [Related]
28. Cost analysis of metallic ureteral stents with 12 months of follow-up.
Taylor ER; Benson AD; Schwartz BF
J Endourol; 2012 Jul; 26(7):917-21. PubMed ID: 22360415
[TBL] [Abstract][Full Text] [Related]
29. Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies.
Chow PM; Hsu JS; Wang SM; Yu HJ; Pu YS; Liu KL
World J Urol; 2014 Jun; 32(3):729-36. PubMed ID: 23933664
[TBL] [Abstract][Full Text] [Related]
30. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
31. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
32. Endourologic management of severely encrusted ureteral stents.
Lojanapiwat B
J Med Assoc Thai; 2005 Sep; 88(9):1203-6. PubMed ID: 16536105
[TBL] [Abstract][Full Text] [Related]
33. Retrograde stenting for obstruction of the renal transplant ureter.
Gerrard ER; Burns JR; Young CJ; Urban DA; Hammontree LN; El-Galley R; Kolettis PN
Urology; 2005 Aug; 66(2):256-60; discussion 260. PubMed ID: 16098351
[TBL] [Abstract][Full Text] [Related]
34. Ureteroiliac artery fistula caused by full-length metallic ureteral stenting in a malignant ureteral obstruction: a case report.
Miyauchi Y; Osaki Y; Naito H; Tsunemori H; Itoh M; Kanenishi K; Norikane T; Sanomura T; Nishiyama Y; Sugimoto M
J Med Case Rep; 2020 Oct; 14(1):195. PubMed ID: 33070773
[TBL] [Abstract][Full Text] [Related]
35. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents.
Elsamra SE; Leavitt DA; Motato HA; Friedlander JI; Siev M; Keheila M; Hoenig DM; Smith AD; Okeke Z
Int J Urol; 2015 Jul; 22(7):629-36. PubMed ID: 25950837
[TBL] [Abstract][Full Text] [Related]
36. Malignant ureteral obstruction: preliminary results of treatment with metallic self-expandable stents.
Flueckiger F; Lammer J; Klein GE; Hausegger K; Lederer A; Szolar D; Tamussino K
Radiology; 1993 Jan; 186(1):169-73. PubMed ID: 8416559
[TBL] [Abstract][Full Text] [Related]
37. Metallic stents for malignant and benign ureteric obstruction.
Wakui M; Takeuchi S; Isioka J; Iwabuchi K; Morimoto S
BJU Int; 2000 Feb; 85(3):227-32. PubMed ID: 10671873
[TBL] [Abstract][Full Text] [Related]
38. The detour extra-anatomic stent--a permanent solution for benign and malignant ureteric obstruction?
Lloyd SN; Tirukonda P; Biyani CS; Wah TM; Irving HC
Eur Urol; 2007 Jul; 52(1):193-8. PubMed ID: 17126477
[TBL] [Abstract][Full Text] [Related]
39. Initial experience with the resonance metallic stent for antegrade ureteric stenting.
Wah TM; Irving HC; Cartledge J
Cardiovasc Intervent Radiol; 2007; 30(4):705-10. PubMed ID: 17508238
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
